Regeneron Pharmaceuticals
A Senior Toxicologist leads nonclinical development programs by designing, conducting, and interpreting regulatory toxicology and pharmacology studies in rodent and non-rodent models. The role involves coordinating cross-functional project teams, managing study budgets and timelines, and authoring primary regulatory documentation for submissions to agencies like the FDA and EMEA.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
5% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Sr. Scientist, Toxicology
Legend Biotech
Associate Director, Regulatory Affairs – Nonclinical Development
Altasciences
Toxicologist
BlueRidge Life Sciences
Regulatory/Project Toxicologist
Roche
Distinguished Scientist, Safety Assessment Project Expert
sanofi us
Vice President of Nonclinical Drug Safety and Toxicology
Remix Therapeutics